Ichinose P et al., 2023: Pig study showing that nine days of fenbendazole in feed strongly induces hepatic CYP1A, and the authors conclude continuous dosing may accelerate the drug's own metabolism through the CYP1A pathway.
Thus, the continuous FBZ administration may accelerate its own in vivo hepatic metabolism through the CYP1A pathway.
Ichinose P et al., 2023: Pig study showing that nine days of fenbendazole in feed strongly induces hepatic CYP1A, and the authors conclude continuous dosing may accelerate the drug's own metabolism through the CYP1A pathway. Animal study; 6 treated female Landrace piglets plus 5 untreated controls; Argentina (UNCPBA, Tandil); fenbendazole in feed for 9 consecutive days at the label regimen for pigs; liver microsomes after slaughter. Funder: CONICET and FONCYT (Argentina). Declared conflicts: none recorded. Product: fenbendazole premix, manufacturer not named. Comparator: untreated control pigs. A 24.5-fold rise in CYP1A activity is the single largest enzyme effect recorded in this sweep and is directly relevant to C5. Study type: animal.
